Leaflet BREVIBLOC 100mg / 10ml solution for infusion
Indicated for: cardiac arrhythmias
Route of administration: infusion
Substance: esmolol (beta blocker)
ATC: C07AB09 (Cardiovascular system | Beta blocking agents | Beta blocking agents, selective)
This medicine may cause dizziness or vertigo.
May lower blood pressure and increase the risk of falls.
Older people may have an increased risk of side effects.
Esmolol is a medication used for the treatment of supraventricular tachycardia and acute hypertension, particularly in emergency situations. It is a cardioselective beta-blocker with rapid action, reducing heart rate and blood pressure.
The medication is administered via intravenous infusion under medical supervision, and the dosage is adjusted based on the patient's response.
Common side effects include hypotension, bradycardia, dizziness, and nausea. In rare cases, more severe adverse effects such as heart failure or bronchospasm may occur.
Esmolol is not recommended for pregnant or breastfeeding women unless the benefits outweigh the risks. Patients should inform their doctor about all medications they are taking to avoid drug interactions.
General data about BREVIBLOC 100mg / 10ml
- Substance: esmolol
- Date of latest medicines list: 01-06-2026
- Product code: W70514001
- Concentration: 100mg / 10ml
- Pharmaceutical form: solution for infusion
- Quantity: 5
- Product type: Generic medicine
- Price: 199.82 RON
- Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.
Concentrations available for esmolol
- 100mg/10ml
- 10mg/ml